4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-23-010720
CHIEF LEGAL OFFICER acquired 167 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Adler Reid G. CHIEF LEGAL OFFICER | 2023-06-30 | Grant or award | +167 | $1.59 | $265 | 11,488 | D |
Loading xslF345X04/form4-07052023_040703.xml…